Federal contract award
75N93021F00002
PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541713 — Research and Development in Nanotechnology |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93018D00013 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $11.3M |
| Current contract value | $11.3M |
| Potential contract value / ceiling | $15.8M |
| Start date | Sep 17, 2021 |
| Current end date | Dec 31, 2026 |
| Potential end date | Dec 31, 2026 |
| Latest award activity | Dec 18, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 18, 2025 | P00010 | $0 | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Sep 24, 2025 | P00009 | $335.0K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Aug 19, 2025 | P00008 | $0 | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Jan 7, 2025 | P00007 | $629.8K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Sep 4, 2024 | P00006 | $442.6K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Jul 15, 2024 | P00005 | $720.4K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Jan 17, 2024 | P00004 | $6.1M | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Nov 8, 2023 | P00003 | $597.0K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Jun 20, 2023 | P00002 | $2.0M | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Aug 22, 2022 | P00001 | $151.9K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
| Sep 17, 2021 | 0 | $253.0K | PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2026-12-31 (60 days from calculation)
- +35 points
- 13 historical awards in this buyer and category group
- +15 points
- 11 recorded award transactions
- +10 points
- Latest award action: 2025-12-18
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.